Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut

European Journal of Immunology

Volumn 46, Issue 4, 2016, Pages 1047-1057

  Monteleone, Ivan ^a   Zorzi, Francesca ^a   Marafini, Irene ^a   Di Fusco, Davide ^a   Dinallo, Vincenzo ^a   Caruso, Roberta ^a   Izzo, Roberta ^a   Franzè, Eleonora ^a   Colantoni, Alfredo ^a   Pallone, Francesco ^a   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Aryl hydrocarbon receptor; Collagen; Crohn's disease; Fibroblasts; Strictures

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AROMATIC HYDROCARBON RECEPTOR; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; COLLAGEN TYPE 3; COLLAGEN TYPE 3A1; INTERLEUKIN 13; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 2-METHYL-2H-PYRAZOLE-3-CARBOXYLIC ACID (2-METHYL-4-O-TOLYLAZOPHENYL)AMIDE; ACTA2 PROTEIN, HUMAN; ACTIN; AZO COMPOUND; COL3A1 PROTEIN, HUMAN; COLLAGEN TYPE I, ALPHA 1 CHAIN; MITOGEN ACTIVATED PROTEIN KINASE; PYRAZOLE DERIVATIVE; TRINITROBENZENESULFONIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; COLON DISEASE; COLONIC FIBROSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; IN VIVO STUDY; INTESTINAL FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; AGED; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; FIBROSIS; GASTROINTESTINAL TRACT; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION;

ACTINS; ADULT; AGED; ANIMALS; AZO COMPOUNDS; COLLAGEN TYPE I; COLLAGEN TYPE III; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLASTS; FIBROSIS; GASTROINTESTINAL TRACT; HUMANS; MICE; MICE, INBRED BALB C; MIDDLE AGED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRAZOLES; RECEPTORS, ARYL HYDROCARBON; TRANSFORMING GROWTH FACTOR BETA1; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84959046709     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445228     Document Type: Article

References (36)

1. Kaser, A., Zeissig, S. and Blumberg, R. S., Inflammatory bowel disease. Annu. Rev. Immunol. 2010. 28: 573-621.
2. Baumgart, D. C. and Sandborn, W. J., Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007. 369: 1641-1657.
3. Thia, K. T., Sandborn, W. J., Harmsen, W. S., Zinsmeister, A. R. and Loftus, E. V., Jr., Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010. 139: 1147-1155.
4. Cosnes, J., Cattan, S., Blain, A., Beaugerie, L., Carbonnel, F., Parc, R. and Gendre, J. P., Long-term evolution of disease behavior of Crohn's disease. Inflamm. Bowel Dis. 2002. 8: 244-250.
5. Rieder, F., Zimmermann, E. M., Remzi, F. H. and Sandborn, W. J., Crohn's disease complicated by strictures: a systematic review. Gut 2013. 62: 1072-1084.
6. Li, C. and Kuemmerle, J. F., Mechanisms that mediate the development of fibrosis in patients with Crohn's disease. Inflamm. Bowel Dis. 2014. 20: 1250-1258.
7. Wynn, T. A. and Ramalingam, T. R., Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012. 18: 1028-1040.
8. Bamba, S., Andoh, A., Yasui, H., Araki, Y., Bamba, T. and Fujiyama, Y., Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J. Gastroenterol. 2003. 38: 548-554.
9. Di Sabatino, A., Jackson, C. L., Pickard, K. M., Buckley, M., Rovedatti, L., Leakey, N. A., Picariello L. et al., Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut 2009. 58: 777-789.
10. Okuno, T., Andoh, A., Bamba, S., Araki, Y., Fujiyama, Y., Fujiyama, M. and Bamba, T., Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand. J. Gastroenterol. 2002. 37: 317-324.
11. Fichtner-Feigl, S., Young, C. A., Kitani, A., Geissler, E. K., Schlitt, H. J. and Strober, W., IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 2008. 135: 2003-2013, 2013 e2001-e2007.
12. Wick, G., Grundtman, C., Mayerl, C., Wimpissinger, T. F., Feichtinger, J., Zelger, B., Sgonc, R. et al., The immunology of fibrosis. Annu. Rev. Immunol. 2013. 31: 107-135.
13. Lawrance, I. C., Wu, F., Leite, A. Z., Willis, J., West, G. A., Fiocchi, C. and Chakravarti, S., A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology 2003. 125: 1750-1761.
14. Gu, Y. Z., Hogenesch, J. B. and Bradfield, C. A., The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 2000. 40: 519-561.
15. Denison, M. S. and Nagy, S. R., Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003. 43: 309-334.
16. Rannug, U., Rannug, A., Sjoberg, U., Li, H., Westerholm, R. and Bergman, J., Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem. Biol. 1995. 2: 841-845.
17. Barouki, R., Coumoul, X. and Fernandez-Salguero, P. M., The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 2007. 581: 3608-3615.
18. Quintana, F. J., The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response. Immunology 2013. 138: 183-189.
19. Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., Macdonald, T. T. et al., Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011. 141: 237-248, e231.
20. Lehmann, G. M., Xi, X., Kulkarni, A. A., Olsen, K. C., Pollock, S. J., Baglole, C. J., Gupta, S. et al., The aryl hydrocarbon receptor ligand ITE inhibits TGFbeta1-induced human myofibroblast differentiation. Am. J. Pathol. 2011. 178: 1556-1567.
21. Lahoti, T. S., Hughes, J. M., Kusnadi, A., John, K., Zhu, B., Murray, I. A., Gowda, K. et al., Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J. Pharmacol. Exp. Ther. 2014. 348: 236-245.
22. Lahoti, T. S., John, K., Hughes, J. M., Kusnadi, A., Murray, I. A., Krishnegowda, G., Amin, S. et al., Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes. Ann. Rheum. Dis. 2013. 72: 1708-1716.
23. Pierre, S., Chevallier, A., Teixeira-Clerc, F., Ambolet-Camoit, A., Bui, L. C., Bats, A. S., Fournet, J. C. et al., Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol. Sci. 2014. 137: 114-124.
24. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W. et al., Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995. 268: 722-726.
25. Corchero, J., Martin-Partido, G., Dallas, S. L. and Fernandez-Salguero, P. M., Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1. Int. J. Exp. Pathol. 2004. 85: 295-302.
26. Peterson, T. C., Hodgson, P., Fernandez-Salguero, P., Neumeister, M. and Gonzalez, F. J., Hepatic fibrosis and cytochrome P450: experimental models of fibrosis compared to AHR knockout mice. Hepatol. Res. 2000. 17: 112-125.
27. Pannu, J., Nakerakanti, S., Smith, E., ten Dijke, P. and Trojanowska, M., Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J. Biol. Chem. 2007. 282: 10405-10413.
28. Sabio, G. and Davis, R. J., TNF and MAP kinase signalling pathways. Semin. Immunol. 2014. 26: 237-245.
29. Biernacka, A., Dobaczewski, M. and Frangogiannis, N. G., TGF-beta signaling in fibrosis. Growth Factors 2011. 29: 196-202.
30. Fichtner-Feigl, S., Fuss, I. J., Young, C. A., Watanabe, T., Geissler, E. K., Schlitt, H. J., Kitani, A. et al., Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2, 4, 6-trinitrobenzene sulfonic acid colitis. J. Immunol. 2007. 178: 5859-5870.
31. Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K. and Kitani, A., IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 2006. 12: 99-106.
32. Andoh, A., Bamba, S., Brittan, M., Fujiyama, Y. and Wright, N. A., Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol. Ther. 2007. 114: 94-106.
33. Wang, C., Xu, C. X., Bu, Y., Bottum, K. M. and Tischkau, S. A., Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling. Carcinogenesis 2014. 35: 703-713.
34. Puga, A., Ma, C. and Marlowe, J. L., The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 2009. 77: 713-722.
35. Aomatsu, T., Imaeda, H., Takahashi, K., Fujimoto, T., Kasumi, E., Yoden, A., Tamai, H. et al., Tacrolimus (FK506) suppresses TNF-alpha-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts. Int. J. Mol. Med. 2012. 30: 1152-1158.
36. Monteleone, G., Caruso, R., Fina, D., Peluso, I., Gioia, V., Stolfi, C., Fantini, M. C. et al., Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 2006. 55: 1774-1780.